Celgene has been one of the dominant biotech players in recent history. Its successful R&D and acquisitions have made the company a contender for the industry’s pole position, and its growing commercialization capabilities have effectively utilized its assets to create a diversified growth profile with a 2020 sales CAGR of almost 20%.
Blue Bottle Coffee – The Craft Alternative to Starbucks? Only time will tell…
From a free Montreal-based “punk” magazine to an international media powerhouse with a $4B valuation.
Company Overview: A third-party logistics provider, Expeditors International of Washington is a global logistics company satisfying the increasingly sophisticated needs of international trade. The Company’s primary services include air and ocean freight transportation and customs brokerage. The Company also provides […]
Why Blue Bird Corporation is the fastest growing school bus brand.
Bio-Pappel, the leading producer of paper and paper-based products in Latin America, underwent a radical shift starting in 2011 to become a truly sustainable company. With 27 production plants in Mexico, United States, and Colombia, and a production process that relies on the use of 100%-recycled inputs, Bio-Pappel is well-positioned to continue generating and capturing value for its customers.
Ranked 2nd in the fast casual restaurant industry in China and capturing 52% market share within the fast casual hot pot segment, Xiabu Xiabu (XBXB) revamped the entire concept of traditional hot pot cuisine since 1998. It differentiates itself from […]
AutoZone: Bringing Customer Focus to the Wild West of Auto-Parts Retailers
By investing in in-house drug research and development, partnering with world class research institutes, and acquiring high potential compounds, Celgene has achieved massive success so far and is positioned to continue to do so.
The real differentiating feature of Palantir is the ability of its operating model to execute engineering talent arbitrage.
